Olin's Second Quarter Call Arrives With Management Forecasting a Range They Haven't Needed Before

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Olin reports after market close, meaning Day 0 captures anticipatory trading before results are released, while Day +1 reflects the market's first full session to digest the actual earnings data.

Historical price action around Olin's earnings reveals significant volatility, particularly in the Day +1 session after results are digested. The stock has averaged an absolute move of 1.83% on Day 0 (anticipation) but a much larger 6.41% on Day +1 (reaction), with intraday ranges averaging 3.97% and 7.25% respectively.

The most dramatic reactions have come after disappointing results or guidance, with October 2025 delivering a -12.45% Day +1 decline and January 2026 producing an -8.87% drop. Even when Olin has beaten estimates modestly, as in May 2026 with a -7.08% Day 0 decline, the market has focused more on forward guidance and macro concerns than the quarterly beat itself.

Investors should prepare for substantial volatility following this release, with historical patterns suggesting the Day +1 session typically delivers the most significant directional move as the market processes not just the headline numbers but management's commentary on demand trends and pricing outlook across the chemical portfolio.

Part 2.2: Options Market Expected Move

The options market is pricing an 11.68% expected move (±$2.59) for the August expiration, which is substantially higher than the historical average Day +1 move of 6.41%. This elevated implied volatility of 68.31% suggests options traders are anticipating a larger-than-typical reaction, possibly reflecting uncertainty around the magnitude of the recovery or concerns about forward guidance in a still-challenging chemical market environment.

Part 3: What Analysts Are Saying

Analyst sentiment on Olin has deteriorated recently, with the average recommendation standing at 3.36 (between Hold and Buy) compared to 3.57 a month ago. The current consensus reflects a cautious stance, with 3 Strong Buys, 10 Holds, and 1 Moderate Sell among 14 analysts covering the stock, down from 4 Strong Buys a month ago.

The average price target of $26.40 implies 19% upside from the current price of $22.19, with estimates ranging from a low of $21.00 (5% downside) to a high of $48.00 (116% upside). This wide dispersion reflects significant disagreement about Olin's recovery trajectory and the sustainability of any margin improvement in its chemical segments.

The recent deterioration in sentiment, marked by one analyst downgrading from Strong Buy and another moving to Moderate Sell, suggests growing concern about the pace of recovery or skepticism about management's ability to navigate the current industry headwinds. The shift comes despite upward revisions to near-term EPS estimates, indicating analysts may be more concerned about the quality and sustainability of earnings rather than the absolute numbers.

Part 4: Technical Picture

Olin enters earnings with a 64% Sell signal from the Barchart Technical Opinion, representing a significant deterioration from 32% Sell a week ago and 56% Sell a month ago. This weakening technical picture reflects mounting pressure as the stock has failed to sustain any meaningful recovery attempts.

Timeframe Analysis:

• Short-term (50% Sell): Moderate sell signal indicates near-term momentum has turned negative heading into the release
• Medium-term (100% Sell): Strong sell signal across all medium-term indicators suggests the intermediate trend remains firmly bearish
• Long-term (50% Sell): Moderate sell signal reflects ongoing weakness in the longer-term trend structure

Trend Characteristics: The technical environment shows Average strength but is Weakening, indicating deteriorating momentum across multiple timeframes that could amplify any negative reaction to disappointing results.

The stock is trading at $22.19, positioned below its 5-day ($22.46), 10-day ($22.58), 50-day ($23.19), 100-day ($25.21), and 200-day ($23.73) moving averages, with only the 20-day average ($21.62) providing support below current levels.

The technical setup is decidedly cautionary heading into earnings, with the stock trapped below all major moving averages except the 20-day and showing deteriorating momentum across all timeframes. The 200-day moving average at $23.73 represents significant overhead resistance, while the 20-day at $21.62 provides the only nearby support level. Given the bearish technical backdrop and elevated options-implied volatility, any disappointment in results or guidance could trigger an accelerated move lower, while a strong beat would need to be substantial to overcome the negative technical momentum and reclaim the key moving average resistance levels above.